Abstract

The maintenance of intestinal homeostasis is a fundamental process critical for organismal integrity. Sitting at the interface of the gut microbiome and mucosal immunity, adaptive and innate lymphoid populations regulate the balance between commensal micro-organisms and pathogens. Checkpoint inhibitors, particularly those targeting the CTLA-4 pathway, disrupt this fine balance and can lead to inflammatory bowel disease and immune checkpoint colitis. Here, we show that CTLA-4 is expressed by innate lymphoid cells and that its expression is regulated by ILC subset-specific cytokine cues in a microbiota-dependent manner. Genetic deletion or antibody blockade of CTLA-4 in multiple in vivo models of colitis demonstrates that this pathway plays a key role in intestinal homeostasis. Lastly, we have found that this observation is conserved in human IBD. We propose that this population of CTLA-4-positive ILC may serve as an important target for the treatment of idiopathic and iatrogenic intestinal inflammation.

Original languageEnglish
Article number9520
Pages (from-to)9520
JournalNature Communications
Volume15
Issue number1
DOIs
Publication statusPublished - 4 Nov 2024

Keywords

  • Animals
  • CTLA-4 Antigen/metabolism
  • Immunity, Innate
  • Homeostasis
  • Humans
  • Mice
  • Intestinal Mucosa/immunology
  • Gastrointestinal Microbiome/immunology
  • Lymphocytes/immunology
  • Colitis/immunology
  • Mice, Inbred C57BL
  • Female
  • Inflammatory Bowel Diseases/immunology
  • Mice, Knockout
  • Male
  • Cytokines/metabolism
  • Disease Models, Animal
  • Immunity, Mucosal

Fingerprint

Dive into the research topics of 'CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner'. Together they form a unique fingerprint.

Cite this